Table 4.

EBV-associated lymphomas in immunodeficient hosts

Lymphoma	EBV frequency	Latency Program
Post-transplantation LPD, B-cell	>90%	Type 3
Post-transplantation LPD, NK/T-cell	>70%	Type 3
Burkitt’s lymphoma (HIV)	25–35%	Type 1
Hodgkin’s lymphoma (HIV)	>80%	Type 2
Primary effusion lymphoma	>80%	Type 1
Plasmablastic lymphoma	~70%	Type 1 or Type 2
Plasmablastic lymphoma, oral type (HIV)	100%	Type 1
Primary CNS lymphoma (HIV)	100%	Type 3
NHLs with primary immune disorders	>90%	Type 3
Iatrogenic immunodeficiency lymphoma	40–50%	Type 3